The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longitudinal clinical performance of a novel tumor-naive minimal residual disease assay in patients with resected stage II and III colorectal cancer: A subset analysis from the GALAXY study in CIRCULATE-Japan.
 
Yoshiaki Nakamura
Consulting or Advisory Role - DAIICHI SANKYO Co., Ltd.; Exact Sciences; Gilead Sciences; Guardant Health Pte Ltd; Natera,Inc.; Premo Partners, Inc.; Roche Ltd./; Seagen,Inc.; Takeda
Speakers' Bureau - Becton Dickinson; CareNet,Inc.; Chugai Pharma; DAIICHI SANKYO Co., Ltd.; Eisai; Guardant Health Japan Corp.; Guardant Health Pte Ltd; Hisamitsu Pharmaceutical; Merck; Miyarisan pharmaceutical; MSD K.K; Taiho Pharmaceutical; Zeria Pharmaceutical
Research Funding - Chugai Pharma (Inst); DAIICHI SANKYO Co., Ltd. (Inst); Genomedia (Inst); Guardant Health (Inst); Guardant Health AMEA, Inc. (Inst); Roche (Inst); Seagen,Inc. (Inst); Tempus (Inst)
 
Kristiyana Kaneva
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
Travel, Accommodations, Expenses - Tempus AI, Inc.
 
Christine Lo
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
 
Farahnaz Islam
Employment - Tempus
 
Seung Won Hyun
Employment - Johnson & Johnson/Janssen; Tempus
Leadership - Johnson & Johnson/Janssen; Tempus
 
Daniel Neems
Employment - Tempus Lab LLC
Stock and Other Ownership Interests - Tempus Lab LLC
Travel, Accommodations, Expenses - Tempus Lab LLC
 
Jason Yamada-Hanff
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Terri Driessen
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
Travel, Accommodations, Expenses - Tempus AI, Inc.
 
Hala Boulos
No Relationships to Disclose
 
Chithra Sangli
Employment - Johnson & Johnson/MedTech
Stock and Other Ownership Interests - ABBVIE/ABBOTT; ABBVIE/ABBOTT; Johnson & Johnson/Janssen; Novo Nordisk; Tempus
 
Richard Blidner
Employment - Tempus
Leadership - Tempus
Stock and Other Ownership Interests - Tempus
Patents, Royalties, Other Intellectual Property - Listed as an inventor on several patents with Tempus
 
Hideaki Bando
Honoraria - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical
 
Robert Tell
Employment - Tempus AI, Inc
Stock and Other Ownership Interests - Tempus AI, Inc.
Research Funding - Tempus AI, Inc.
Travel, Accommodations, Expenses - Tempus AI, Inc.
 
Daisuke Kotani
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Lilly Japan; Merck Serono; MSD; Novartis; Ono Pharmaceutical; Pfizer; Sysmex; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Seagen; Takeda
Research Funding - CMIC (Inst); CMIC (Inst); IQvia (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); SERVIER (Inst); Syneos Health (Inst)
 
Kate Sasser
Employment - Genmab; Tempus
Leadership - Tempus
Stock and Other Ownership Interests - Genmab; Tempus AI
Travel, Accommodations, Expenses - Genmab; Tempus
 
Halla Nimeiri
Employment - Northwestern Medicine; Tempus AI
Stock and Other Ownership Interests - Abbvie
 
Eiji Oki
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Guardant Health
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Merck; MSD K.K.; Takeda
Consulting or Advisory Role - Sumitomo Corp.
Research Funding - Amgen (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Eisai (Inst); FALCO biosystems Ltd. (Inst); Medical & Biological Laboratories Co., Ltd. (Inst); Merus (Inst); Molecular Health (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)